AbstractRecurrent pleural malignant effusion is a common problem which can be treated by inducing symphysis of the pleural sheets. Many different drugs administered into the pleural space can be used to achieve this. The drugs cause an inflammatory response, which in turn is believed to cause the symphysis. Comparatively little has been published on the degree of pleural inflammation and the systemic response and whether this will affect the outcome.The aim of this study was to describe the systemic inflammatory reaction following instillation of a chemical agent into the pleura and to investigate whether this had any predictive value for the outcome (i.e. the pleurodesis). The markers investigated were simple ones: erythrocyte sedimentatio...
AbstractBackground42–77% of exudative pleural effusions are due to malignant diseases (Marel et al.,...
Background. Growth factors are key inducers of fibrosis but can also mediate inflammatory responses ...
AbstractBackgroundPleurodesis fails in 10–40% of patients with recurrent malignant pleural effusions...
AbstractRecurrent pleural malignant effusion is a common problem which can be treated by inducing sy...
Malignant pleural effusions are a common complication of advanced malignancy, have a poor prognosis ...
Metastatic or primary (mesothelioma) malignancy of the pleura often generates major pleura] effusion...
Metastatic or primary (mesothelioma) malignancy of the pleura often generates major pleura] effusio...
Repeated thoracentesis may cause pleural inflammation and induce local release of proinfammatory cyt...
Thoracoscopic chemically induced pleurodesis in the treatment of malignant pleural effusion as a mod...
AbstractBackground42–77% of exudative pleural effusions are due to malignant diseases (Marel et al.,...
Chemical pleurodesis is a therapeutic method often used to prevent pleural fluid accumulation in pat...
Acute-phase markers, such as C-reactive protein (CRP), interleukin-6 (IL-6) and tumor necrosis facto...
SummaryAcute-phase markers, such as C-reactive protein (CRP), interleukin-6 (IL-6) and tumor necrosi...
PURPOSE OF REVIEW: Malignant pleural effusions are common, and pleurodesis remains the best method t...
PURPOSE OF REVIEW: Malignant pleural effusions are common, and pleurodesis remains the best method t...
AbstractBackground42–77% of exudative pleural effusions are due to malignant diseases (Marel et al.,...
Background. Growth factors are key inducers of fibrosis but can also mediate inflammatory responses ...
AbstractBackgroundPleurodesis fails in 10–40% of patients with recurrent malignant pleural effusions...
AbstractRecurrent pleural malignant effusion is a common problem which can be treated by inducing sy...
Malignant pleural effusions are a common complication of advanced malignancy, have a poor prognosis ...
Metastatic or primary (mesothelioma) malignancy of the pleura often generates major pleura] effusion...
Metastatic or primary (mesothelioma) malignancy of the pleura often generates major pleura] effusio...
Repeated thoracentesis may cause pleural inflammation and induce local release of proinfammatory cyt...
Thoracoscopic chemically induced pleurodesis in the treatment of malignant pleural effusion as a mod...
AbstractBackground42–77% of exudative pleural effusions are due to malignant diseases (Marel et al.,...
Chemical pleurodesis is a therapeutic method often used to prevent pleural fluid accumulation in pat...
Acute-phase markers, such as C-reactive protein (CRP), interleukin-6 (IL-6) and tumor necrosis facto...
SummaryAcute-phase markers, such as C-reactive protein (CRP), interleukin-6 (IL-6) and tumor necrosi...
PURPOSE OF REVIEW: Malignant pleural effusions are common, and pleurodesis remains the best method t...
PURPOSE OF REVIEW: Malignant pleural effusions are common, and pleurodesis remains the best method t...
AbstractBackground42–77% of exudative pleural effusions are due to malignant diseases (Marel et al.,...
Background. Growth factors are key inducers of fibrosis but can also mediate inflammatory responses ...
AbstractBackgroundPleurodesis fails in 10–40% of patients with recurrent malignant pleural effusions...